LBO — MYMICHIGAN MEDICAL CENTER GLADWIN
IRR: 18.3% | MOIC: 2.32x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.3%
IRR
2.32x
MOIC
$39.7M
Entry EV
$63.9M
Exit EV
$20.5M
Equity Invested
Sources & Uses
S&UTotal · $39.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $15.4M | 38.8% | |
| Sub Debt | $3.9M | 9.7% | |
| Equity | $20.5M | 51.5% | |
| Enterprise Value | $38.6M | 97.1% | |
| Transaction Fees | $1.2M | 2.9% | |
| Total Uses | $39.7M | 100.0% |
Interpretation
INTAt 2.32x MOIC and 18.3% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $6.1M |
| Exit Ev | $63.9M |
| Net Debt At Exit | $16.6M |
| Equity At Exit | $47.4M |
| Equity Invested | $20.5M |
| Total Value Created | $26.9M |
| Value From Growth | $23.4M |
| Value From Multiple | $1.9M |
| Value From Deleveraging | $2.7M |